Helaina

Helaina is a biotechnology company founded in 2019 that focuses on reimagining human nutrition by producing bio-identical proteins found in human milk. Using advanced precision fermentation, the company programs microorganisms such as yeast to act as manufacturing systems, effectively identifying and replicating specific genetic instructions for functional human proteins. This proprietary platform allows Helaina to produce molecules that are structurally and functionally equivalent to those found naturally in the body, such as lactoferrin. The company’s development process is designed to accelerate innovation, reducing discovery and scale-up timelines while maintaining rigorous scientific standards within its New York-based laboratory facility.

The company's primary innovation, effera®, serves as a bio-identical lactoferrin ingredient designed to provide health benefits related to immunity, gut health, women's health, and active nutrition. By offering a sustainable and scalable alternative to bovine-derived versions, Helaina aims to transform the standard of nutrition for all ages, including early-life nutrition. The company has secured significant venture capital backing to support its transition from research and development to commercial enterprise, partnering with major industry players like Nestlé to integrate its bioactive proteins into a broader range of consumer health and wellness products. Helaina's approach emphasizes scientific rigor and clinical proof, demonstrating significant advantages in immune support and absorption efficiency compared to conventional ingredients.